patent/CN-105408336-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105408336-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8ab16a9037ecb102a8cb8ae05cc8a8
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate	2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d2576cd917fac268d5cf46f79f693c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c705aad19b8edbb62f7d75696ef93844
publicationDate	2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-105408336-A
titleOfInvention	Spiro-lactam NMDA receptor modulators and uses thereof
abstract	Compounds with enhanced potency in modulating NMDA receptor activity are disclosed. Such compounds are contemplated for use in the treatment of diseases such as depression and related disorders. Also disclosed are orally usable formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109937204-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109890825-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112218866-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11530223-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578072-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113966337-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512051-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109843889-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109890825-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109843889-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021228123-A1
priorityDate	2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102186883-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011100585-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466239128

Total number of triples: 41.